ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,731 | -42.1% | 11,194 | -9.4% | 0.00% | – |
| Q2 2023 | $92,839 | +104.5% | 12,362 | +23.1% | 0.00% | – |
| Q1 2023 | $45,394 | -44.4% | 10,043 | +38.7% | 0.00% | – |
| Q4 2022 | $81,617 | -94.4% | 7,242 | -91.6% | 0.00% | – |
| Q1 2022 | $1,455,000 | -27.8% | 86,072 | -8.2% | 0.00% | -100.0% |
| Q4 2021 | $2,016,000 | +275.4% | 93,798 | +1190.9% | 0.00% | – |
| Q3 2021 | $537,000 | +107.3% | 7,266 | +53.4% | 0.00% | – |
| Q2 2021 | $259,000 | -81.5% | 4,738 | -75.0% | 0.00% | – |
| Q1 2021 | $1,397,000 | +34825.0% | 18,948 | +37796.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |